Effectiveness of Sumatriptan in Reducing Productivity Loss Due to Migraine: Results of a Randomized, Double-Blind, Placebo-Controlled Clinical Trial
- 31 August 2000
- journal article
- clinical trial
- Published by Elsevier BV in Mayo Clinic Proceedings
- Vol. 75 (8), 782-789
- https://doi.org/10.4065/75.8.782
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Changes in Resource Use and Outcomes for Patients With Migraine Treated With SumatriptanArchives of Internal Medicine, 1999
- Reduction of Labor Costs Associated With Treating Migraine in the WorkplaceArchives of Internal Medicine, 1999
- Sumatriptan Injection Reduces Productivity Loss During a Migraine AttackArchives of Internal Medicine, 1998
- Lost Workdays and Decreased Work Effectiveness Associated With Headache in the WorkplaceJournal of Occupational and Environmental Medicine, 1997
- A Multinational Investigation of the Impact of Subcutaneous SumatriptanPharmacoEconomics, 1997
- Impact of Sumatriptan on Workplace Productivity, Nonwork Activities, and Health‐Related Quality of Life Among Hospital Employees With MigraineHeadache: The Journal of Head and Face Pain, 1996
- Efficacy of subcutaneous sumatriptan in repeated episodes of migraineNeurology, 1993
- Impact of Migraine in the United States: Data from the National Health Interview SurveyHeadache: The Journal of Head and Face Pain, 1993
- Healthcare Resource and Lost Labour Costs of Migraine Headache in the USPharmacoEconomics, 1992
- Prevalence of Migraine Headache in the United StatesJAMA, 1992